CPRX logo

Catalyst Pharmaceuticals (CPRX) Revenue

Annual revenue:

$491.73M+$93.53M(+23.49%)
December 31, 2024

Summary

  • As of today (July 1, 2025), CPRX annual revenue is $491.73 million, with the most recent change of +$93.53 million (+23.49%) on December 31, 2024.
  • During the last 3 years, CPRX annual revenue has risen by +$350.90 million (+249.16%).
  • CPRX annual revenue is now at all-time high.

Performance

CPRX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

Quarterly revenue:

$141.42M-$399.00K(-0.28%)
March 31, 2025

Summary

  • As of today (July 1, 2025), CPRX quarterly revenue is $141.42 million, with the most recent change of -$399.00 thousand (-0.28%) on March 31, 2025.
  • Over the past year, CPRX quarterly revenue has increased by +$42.91 million (+43.56%).
  • CPRX quarterly revenue is now -0.28% below its all-time high of $141.82 million, reached on December 31, 2024.

Performance

CPRX Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

TTM revenue:

$534.65M+$42.91M(+8.73%)
March 31, 2025

Summary

  • As of today (July 1, 2025), CPRX TTM revenue is $534.65 million, with the most recent change of +$42.91 million (+8.73%) on March 31, 2025.
  • Over the past year, CPRX TTM revenue has increased by +$123.30 million (+29.97%).
  • CPRX TTM revenue is now at all-time high.

Performance

CPRX TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

CPRX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+23.5%+43.6%+30.0%
3 y3 years+249.2%+228.2%+247.8%
5 y5 years+380.6%+385.4%+346.4%

CPRX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+249.2%-0.3%+166.3%at high+213.6%
5 y5-yearat high+380.6%-0.3%+382.4%at high+352.4%
alltimeall timeat high>+9999.0%-0.3%>+9999.0%at high>+9999.0%

CPRX Revenue History

DateAnnualQuarterlyTTM
Mar 2025
-
$141.42M(-0.3%)
$534.65M(+8.7%)
Dec 2024
$491.73M(+23.5%)
$141.82M(+10.2%)
$491.73M(+6.8%)
Sep 2024
-
$128.69M(+4.9%)
$460.48M(+6.0%)
Jun 2024
-
$122.71M(+24.6%)
$434.48M(+5.6%)
Mar 2024
-
$98.51M(-10.9%)
$411.35M(+3.3%)
Dec 2023
$398.20M(+85.9%)
$110.57M(+7.7%)
$398.20M(+14.3%)
Sep 2023
-
$102.69M(+3.1%)
$348.39M(+15.0%)
Jun 2023
-
$99.58M(+16.7%)
$302.95M(+18.1%)
Mar 2023
-
$85.37M(+40.5%)
$256.48M(+19.7%)
Dec 2022
$214.20M(+52.1%)
$60.76M(+6.1%)
$214.20M(+11.7%)
Sep 2022
-
$57.24M(+7.8%)
$191.75M(+12.5%)
Jun 2022
-
$53.11M(+23.3%)
$170.47M(+10.9%)
Mar 2022
-
$43.09M(+12.5%)
$153.72M(+9.1%)
DateAnnualQuarterlyTTM
Dec 2021
$140.83M(+18.3%)
$38.31M(+6.6%)
$140.83M(+5.5%)
Sep 2021
-
$35.95M(-1.1%)
$133.54M(+5.2%)
Jun 2021
-
$36.37M(+20.4%)
$126.90M(+5.6%)
Mar 2021
-
$30.20M(-2.6%)
$120.14M(+0.9%)
Dec 2020
$119.07M(+16.4%)
$31.02M(+5.8%)
$119.07M(+0.8%)
Sep 2020
-
$29.32M(-1.0%)
$118.18M(-1.3%)
Jun 2020
-
$29.61M(+1.6%)
$119.76M(+0.6%)
Mar 2020
-
$29.14M(-3.3%)
$118.99M(+16.3%)
Dec 2019
$102.31M(>+9900.0%)
$30.12M(-2.5%)
$102.31M(+40.8%)
Sep 2019
-
$30.90M(+7.1%)
$72.68M(+73.9%)
Jun 2019
-
$28.84M(+131.7%)
$41.79M(+222.7%)
Mar 2019
-
$12.45M(+2389.7%)
$12.95M(+2489.7%)
Dec 2018
$500.00K(+2.2%)
$500.00K(+2.2%)
$500.00K(+2.2%)
Dec 2010
$489.00K
$489.00K
$489.00K

FAQ

  • What is Catalyst Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals annual revenue year-on-year change?
  • What is Catalyst Pharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals quarterly revenue year-on-year change?
  • What is Catalyst Pharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals TTM revenue year-on-year change?

What is Catalyst Pharmaceuticals annual revenue?

The current annual revenue of CPRX is $491.73M

What is the all time high annual revenue for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high annual revenue is $491.73M

What is Catalyst Pharmaceuticals annual revenue year-on-year change?

Over the past year, CPRX annual revenue has changed by +$93.53M (+23.49%)

What is Catalyst Pharmaceuticals quarterly revenue?

The current quarterly revenue of CPRX is $141.42M

What is the all time high quarterly revenue for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high quarterly revenue is $141.82M

What is Catalyst Pharmaceuticals quarterly revenue year-on-year change?

Over the past year, CPRX quarterly revenue has changed by +$42.91M (+43.56%)

What is Catalyst Pharmaceuticals TTM revenue?

The current TTM revenue of CPRX is $534.65M

What is the all time high TTM revenue for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high TTM revenue is $534.65M

What is Catalyst Pharmaceuticals TTM revenue year-on-year change?

Over the past year, CPRX TTM revenue has changed by +$123.30M (+29.97%)
On this page